Rankings
▼
Calendar
AKBA Q1 2018 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AKBA
Akebia Therapeutics, Inc.
$366M
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$46M
+120.1% YoY
Gross Profit
-$15M
-33.7% margin
Operating Income
-$24M
-53.3% margin
Net Income
-$23M
-51.0% margin
EPS (Diluted)
$-0.48
QoQ Revenue Growth
-47.4%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$21M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$443M
Total Liabilities
$246M
Stockholders' Equity
$197M
Cash & Equivalents
$158M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$46M
$21M
+120.1%
Gross Profit
-$15M
-$39M
+60.5%
Operating Income
-$24M
-$45M
+45.5%
Net Income
-$23M
-$45M
+47.4%
← FY 2018
All Quarters
Q2 2018 →